KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Change in Inventory (2021 - 2025)

Novavax has reported Change in Inventory over the past 5 years, most recently at -$2.1 million for Q4 2025.

  • Quarterly results put Change in Inventory at -$2.1 million for Q4 2025, down 1236.51% from a year ago — trailing twelve months through Dec 2025 was $3.2 million (up 125.09% YoY), and the annual figure for FY2025 was $3.2 million, up 125.09%.
  • Change in Inventory for Q4 2025 was -$2.1 million at Novavax, down from $3.8 million in the prior quarter.
  • Over the last five years, Change in Inventory for NVAX hit a ceiling of $304.2 million in Q2 2022 and a floor of -$16.8 million in Q1 2024.
  • Median Change in Inventory over the past 5 years was $4.0 million (2025), compared with a mean of $32.4 million.
  • Biggest five-year swings in Change in Inventory: soared 478.62% in 2022 and later crashed 1236.51% in 2025.
  • Novavax's Change in Inventory stood at $8.9 million in 2021, then soared by 478.62% to $51.3 million in 2022, then crashed by 115.75% to -$8.1 million in 2023, then soared by 102.34% to $189000.0 in 2024, then plummeted by 1236.51% to -$2.1 million in 2025.
  • The last three reported values for Change in Inventory were -$2.1 million (Q4 2025), $3.8 million (Q3 2025), and $4.0 million (Q2 2025) per Business Quant data.